The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects, and toxicity.
about
Assessment of cord blood unit characteristics on the day of transplant: comparison with data issued by cord blood banks.Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials.Cryopreservation of hematopoietic stem cells.Hematopoietic SCT with cryopreserved grafts: adverse reactions after transplantation and cryoprotectant removal before infusion.Cryopreservation of Endothelial Cells in Various Cryoprotective Agents and Media - Vitrification versus Slow Freezing Methods.Evaluation of distinct freezing methods and cryoprotectants for human amniotic fluid stem cells cryopreservationInfusion of hemolyzed red blood cells within peripheral blood stem cell grafts in patients with and without sickle cell diseaseStability of cryopreserved white blood cells (WBCs) prepared for donor WBC infusions.Preservation of stem cells.Historical perspectives and the future of adverse reactions associated with haemopoietic stem cells cryopreserved with dimethyl sulfoxide.Autologous hematopoietic progenitor cell transplantation for multiple myeloma through an outpatient program.Light-chain amyloidosis: SCT, novel agents and beyond.Automatic washing of thawed haematopoietic progenitor cell grafts: a preclinical evaluation.Safe and effective cryopreservation methods for long-term storage of human-amniotic-fluid-derived stem cells.Optimisation and quality control of cell processing for autologous stem cell transplantation.Febrile reaction associated with the infusion of haploidentical peripheral blood stem cells: incidence, clinical features, and risk factors.A steady-state mass transfer model of removing CPAs from cryopreserved blood with hollow fiber modules.In situ spectroscopic quantification of protein-ice interactions.Optimization of Human Peripheral Blood Mononuclear Cells (PBMCs) Cryopreservation.Effect of the polydispersity of RBCs on the recovery rate of RBCs during the removal of CPAs.Transient loss of consciousness in pediatric recipients of dimethylsulfoxide (DMSO)-cryopreserved peripheral blood stem cells independent of morphine co-medication.Neurotoxicity upon infusion of dimethylsulfoxide-cryopreserved peripheral blood stem cells in patients with and without pre-existing cerebral disease.Variation in dimethyl sulfoxide use in stem cell transplantation: a survey of EBMT centres.Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation.Cell loss and recovery in umbilical cord blood processing: a comparison of postthaw and postwash samples.Adverse events of cryopreserved hematopoietic stem cell infusions in adults: a single-center observational study.Bilateral thalamic infarction after reinfusion of DMSO-preserved autologous stem-cells.Reduction of DMSO concentration in cryopreservation mixture from 10% to 7.5% and 5% has no impact on engraftment after autologous peripheral blood stem cell transplantation: results of a prospective, randomized study.Unloading of cryoprotectants from cryoprotectant-loaded cells on a microfluidic platform.Cryopreservation of Human Adipose-Derived Stem Cells in Combination with Trehalose and Reversible Electroporation.Clinical methods of cryopreservation for donor lymphocyte infusions vary in their ability to preserve functional T-cell subpopulations.
P2860
Q31048572-694B2C6E-6F14-48D3-B77A-EF236529AE21Q34469147-DCD5B9BD-8938-403B-AF45-DC829C2095ECQ34607937-968543EB-6EFD-472E-9B04-72B68F9F6626Q35571628-4A875BEC-35C4-48A8-AAC5-5DE43BC92081Q35927203-E62D46AF-A99B-40F5-92A3-22A40261766EQ35992742-8E5626B3-FF84-4944-B860-8D417FFE1943Q36057559-E6066AB0-4D17-433C-915B-DE3F1DAAB3A8Q36375715-0617C918-14D4-4131-B47B-A1D082432ECCQ37666673-F9753A57-67FC-4E27-B91E-804AEAB60019Q37851868-11BC6112-8A16-49C7-8999-4801C77813DFQ38025703-4405F9C3-5DC1-4D23-8C5F-9212E15A7854Q38056010-8D8F77D1-096F-4A29-ABD1-7D86F1C11A40Q38880448-6F8438E4-0E22-42CE-A80D-A1017AC66DFAQ38914169-130E68B8-3C63-4DBB-8722-A4DB29E6F4FEQ38982450-982FB685-310E-4F9B-A55E-3E9FE3161842Q40150595-A9D5EF38-4CBE-4AD2-953D-F58633D5DE18Q40945922-9B901EA4-9CF8-491D-BD50-005501323CF7Q41834297-0D14BE34-1091-4109-9E7C-2DAE17FD7D2AQ41944870-1478B692-4F6F-45A4-8A6F-67FC2A016DA4Q42094115-75439922-DBF0-4C32-A7CD-7F3BC536E94EQ42574048-DF7513B7-650D-48DB-97C3-5DD47509C58EQ45868221-EADB6267-C285-4CDC-B78F-3400DE98FF59Q46619100-192A4021-E3B8-4FC2-A255-291F517F8BD3Q46734866-786E8356-4688-4CD2-AB0F-2652FCCE1189Q46863074-4B90BC3D-489D-4A48-B88C-C85389981346Q47825765-EB275B3E-0F48-4319-A9B3-BA706FC7887DQ48369137-81403F25-A0CF-4E3D-B97D-4D9677834776Q50134617-8A9E68A6-701E-4884-8C4E-4494353B17B9Q50214896-8E670412-436B-445F-9B5E-35A3A75A6BABQ51264749-0C9CA284-7E54-4B63-B240-49481DD7A61EQ52774309-51CE776F-DDEC-417D-849B-C01A7D24906A
P2860
The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects, and toxicity.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
The role of depletion of dimet ...... y, side effects, and toxicity.
@en
The role of depletion of dimet ...... y, side effects, and toxicity.
@nl
type
label
The role of depletion of dimet ...... y, side effects, and toxicity.
@en
The role of depletion of dimet ...... y, side effects, and toxicity.
@nl
prefLabel
The role of depletion of dimet ...... y, side effects, and toxicity.
@en
The role of depletion of dimet ...... y, side effects, and toxicity.
@nl
P2093
P1476
The role of depletion of dimet ...... y, side effects, and toxicity.
@en
P2093
P304
P356
10.1016/J.BBMT.2003.09.016
P577
2004-02-01T00:00:00Z